Invention Application
- Patent Title: STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
-
Application No.: US17060337Application Date: 2020-10-01
-
Publication No.: US20210023193A1Publication Date: 2021-01-28
- Inventor: Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K39/385 ; A61K39/39
Abstract:
The invention relates to activated Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides and processes for their preparation. The invention also relates to immunogenic conjugates comprising Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides covalently linked to a carrier protein, processes for their preparation and immunogenic compositions and vaccines comprising them.
Public/Granted literature
- US11426456B2 Streptococcus pneumoniae capsular polysaccharides and conjugates thereof Public/Granted day:2022-08-30
Information query
